Jones, Robin L ;
Ratain, Mark J ;
O'Dwyer, Peter J...
Jones , R L , Ratain , M J , O'Dwyer , P J , Siu , L L , Jassem , J , Medioni , J , DeJonge , M , Rudin , C , Sawyer , M , Khayat , D , Awada , A , de Vos-Geelen , J M P G M , Evans , T R J , Obel , J , Brockstein , B , DeGreve , J , Baurain , J-F , Maki , R , D'Adamo , D , Dickson , M , Undevia , S , Geary , D , Janisch , L , Bedard , P L , Razak , A R A , Kristeleit , R , Vitfell-Rasmussen , J , Walters , I , Kaye , S B & Schwartz , G 2019 , ' Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours ' , European Journal of Cancer , vol. 120 , pp. 132-139 . https://doi.org/10.1016/j.ejca.2019.07.024.
,
2019
